122 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
3 May 24
Additional proxy soliciting materials
4:11pm
PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm until the close of the 2025 annual general meeting of shareholders or until
8-K
sm1jx vzsnv0
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
PX14A6G
epwy9ums 9t
1 Jun 23
Letter to shareholders
2:01pm
S-8
pxgzddy3xgd6
26 May 23
Registration of securities for employees
4:39pm
8-K
1pi wdspmwtni
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
tztg4vck2pqjrikzg
11 May 23
Letter to shareholders
11:34am
PX14A6G
pp63gad
5 May 23
Letter to shareholders
11:17am
PX14A6G
3mv87c
3 May 23
Letter to shareholders
2:53pm
DEFA14A
87pjb1u8z8 9q1ps
2 May 23
Additional proxy soliciting materials
4:39pm
DEFA14A
d06y84jz vdn7
28 Apr 23
Additional proxy soliciting materials
4:03pm
PX14A6G
pc87qstvqrs654hrp
26 Apr 23
Letter to shareholders
10:20am